Anti-hepatocellular carcinoma activities of novel hydrazone derivatives via downregulation of interleukin-6
Sign Up to like & getrecommendations! Published in 2024 at "RSC Advances"
DOI: 10.1039/d4ra05854b
Abstract: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related morbidity worldwide. Sorafenib is a first-line drug for the treatment of HCC, however, it is reported to cause serious adverse effects and may lead… read more here.
Keywords: hepatocellular carcinoma; downregulation interleukin; anti hepatocellular; hydrazone derivatives ... See more keywords